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Summary 
HTLV-1 is implicated in the development of diverse diseases.  However, most HTLV-l-infected 
individuals remain asymptomatic. How HTLV-1 infection leads to disparate consequences remains 
a mystery, despite extensive investigation of HTLV-1 isolates from infected individuals.  As in 
human infection, experimental HTLV-1 infection in rabbits is generally benign, although HTLV- 
1-infected rabbit T  cell lines that mediate lethal leukemia-like disease have been reported.  We 
report here that thymuses from mature outbred rabbits inoculated with a lethal HTLV-1 T cell 
line (RI-I/K34) showed morphological and biochemical evidence of apoptosis, whereas thymuses 
from rabbits inoculated with nonlethal HTLV-1 T cell lines showed no signs of apoptosis. Exposure 
of rabbit or human lymphocytes to purified virus from RH/K34 caused rapid induction of apoptosis, 
providing an in vitro correlate to the pathogenic effects. By contrast, virus isolated from a nonlethal 
cell line mediated dose-dependent lymphocyte proliferation.  These data implicate lymphocyte 
apoptosis as a potential mechanism by which the lethal HTLV-1 cell line causes fulminant disease 
and provide a means to identify factors contributing to HTLV-1 disease. Results from this HTLV-1 
infection model can provide insight into variations in HTLV-1 pathogenicity in human infection. 
H 
'TLV-1 infection has been associated with adult T  cell 
.leukemia/lymphoma  (ATLL)  (1,  2)  and  HTLV-1- 
associated  myelopathy  (3).  Extensive  studies  of HTLV-1 
genomic variability reveal a high degree of sequence conser- 
vation among isolates from distinct endemic areas (4, 5); and 
no  specific  mutation  can be linked  to  HTLV-l-associated 
pathology (6, 7).  Rabbits can be infected with HTLV-1 (8, 
9), and, in some reported cases, lethal ATLL-like disease occurs 
(10, 11). As in human infection, primary structural compar- 
isons of HTLV-l-causing asymptomatic infection with virus- 
mediating lethal disease in rabbits provide no dues to mech- 
anisms of HTLV-1 pathogenicity  (12). 
Apoptosis, a form of programmed cell death,  can be in- 
duced by a number of different factors (13-15) and has been 
implicated in pathogenicity related to infection with certain 
viruses, including human immunodeficiency virus (16-19), 
chicken anemia virus (20), and feline leukemia virus (21). To 
date, apoptosis has not been implicated in HTLV-1 infection, 
although Debatin et al.  (22) report that cells from patients 
with HTLV-1 leukemia express the surface antigen APO-1 
and undergo in vitro apoptosis when exposed to anti-APO-1. 
Exposure of normal lymphocytes to cell-free HTLV-1 causes 
cell activation  (23-26). 
The present report documents that  an HTLV-l-infected 
rabbit T cell line (RH/K34) that caused lethal leukemic-like 
disease (12) induced apoptosis in lymphoid organs of inocu- 
lated rabbits. Furthermore, virus isolated from RH/K34 in- 
duced in vitro apoptosis of rabbit and human lymphocytes. 
In  contrast,  virus from  a nonlethal  HTLV-l-infected  cell 
(RH/K30) induced lymphoproliferation in a dose-responsive 
manner. The lethal property of RH/K34 derives from factors 
other than the primary structure of the infecting virus; other 
HTLV-l-infected cell lines harboring the RH/K34 provirus 
do not cause leukemia (12), and virus isolated from these cells 
does not induce apoptosis. 
Materials and Methods 
Animals.  New Zealand White rabbits were given intravenous 
injections of HTLV-l-transformed ceils (2-3  x  10  s cells in 1-2 
ml saline) or uninfected rabbit PBMC. Rabbits were monitored 
daily for temperature  and weight.  HTLV-l-ins  and control 
animals were necropsied at various times after inoculation and tissues 
were taken for study. 
Cell Lines and Culture.  HTLV-l-transformed  rabbit T cell lines 
(RH/K30, RH/K34, RHT-16) were derived and maintained in 
complete medium,  as described previously (27). RPMI K30 and 
RPMI K34, two human HTLV-l-infected B cell lines, were de- 
rived by coculture of RPMI 8226, a human myeloma cell line, with 
irradiated RH/K30 or RH/K34, respectively. 
PBMC isolated from rabbit or human blood, as described (27), 
were  incubated  at  a density  of 2  x  106 cells/ml  in  complete 
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was assessed by trypan blue exclusion. 
Cell activation was measured by [~H]thymidine  incorporation 
after incubation with purified virus. Cells were seeded in triplicate 
in round-bottomed microculture plates at a density of 1.0  x  10  s 
ceUs/weU in 100/*1 of  medium. Human riD2 (100 U/ml; Biosource 
International, Inc., Camarillo, CA) was added to a second set of 
cultures.  Purified HTLV-1 (50  /A)  was  added to  each well. 
[3H]thymidine (1/~Ci/well; sp act, 6.7 Ci/mmol; Dupont-NEN, 
Boston, MA) was added on day 3; after 12 h, cells were harvested 
and thymidine incorporation was measured by liquid scintillation 
counting. Data reported are the mean of triplicate cultures. 
Experiments to determine the effects  of brief exposure to virus 
used techniques  described for HIV-1 (17). Rabbit PBMC (5  x  106) 
were incubated with virus for 1 h at 37~  washed in PBS con- 
taining 2 mM EDTA, and treated with 2.5 mg/ml trypsin for 10 
min at 25~  Digestion was stopped by the addition of complete 
medium. Cytoplasmic extracts were prepared from an aliquot of 
the cells, and p24 gag protein concentration was determined by 
antigen capture ELISA (Coulter Corp., Hialeah, FL). Aliquots of 
the trypsinized cells were monitored for viability over a 4-d period. 
Virus Purification.  Virus  was purified by a modification of the 
method of  Kimata et al. (25). HTLV-1 cell cultures were centrifuged 
at low speed, and supernatants  were taken and centrifuged at 25,000 
rpm for 1 h at 4~  Pellets were resuspended in PBS, loaded onto 
20-60% continuous sucrose gradients in PBS, and centrifuged at 
25,000 rpm for 18 h at 4~  Fractions were tested for sucrose con- 
centration by refractometry and for protein concentration by the 
BCA protein assay (Pierce Chemical Co., Rockford, IL). Pooled 
fractions were diluted 10-fold in PBS and centrifuged at 25,000 
rpm for 1 h; pellets were resuspended in PBS and virus concentra- 
tion estimated by determination of p24 gag protein. 
Electron and Light Microscopy.  Rabbit or human PBMC exposed 
to HTLV-1 virus particles were washed in medium and pelleted. 
Thymuses from HTLV-l-infected or control rabbits were fixed in 
buffered formalin (pH 7.4) and processed. Paraffin sections were 
stained with hematoxylin  and eosin. Cell  pellets and thymuses  were 
fixed for 2 h at 4~  in 2.5% glutaraldehyde in Millonig's buffer 
(285 mosM, pH 7.4), postfixed  in 1% osmium tetroxide,  dehydrated, 
embedded into Spurr's resin, sectioned  (70-90 nm thickness), stained 
with uranyl acetate and lead citrate (JFE Enterprise, Brookville, 
MD), and examined in a transmission electron microscope (EM 
IOC; Carl Zeiss, Inc., Thornwood,  NY). 
Flow Cytometry Analysis.  Cells  were washed in ice-cold PBS 
containing 0.1% BSA and 0.01% NAN3, and reacted with FITC- 
conjugated mAbs (Spring Valley Laboratories, Woodbine, MD) 
directed against CD4 (Ken-4), CD8 (12.C7), or surface Ig (NRBL). 
Subsequently, cells were exposed to 1 #g/ml ethidium bromide 
(Sigma Chemical Co., St. Louis, MO)  for 30 rain, as described 
(15). Cells were analyzed by flow cytometry using Lysys  II soft- 
ware (Becton Dickinson & Co., Mountain View, CA). 
DNA Fragmentation  Assays.  DNA was extracted from PBMC 
or from rabbit thymuses as previously  described (28), and fraction- 
ated on a 1.8% agarose/ethidium bromide gel. 
Results and Discussion 
Apoptosis in HTLV-l-infected Rabbit Thymus.  12 mature 
female  rabbits  were inoculated with  a dose (2  x  108) of 
RH/K34 cells,  seven control rabbits were given an equal 
number of RH/K30 cells and one was inoculated with unin- 
fected rabbit PBMC. Animals inoculated with RH/K34 de- 
veloped an ATLL-like disease and died 6-10 d after inocula- 
tion. Pathological findings included atypical lymphocytes in 
the circulation and leukemic infiltrates in lymph node, lung, 
liver, and spleen (Simpson, R. M., manuscript in prepara- 
tion). Serial necropsy showed that by 4 d after inoculation, 
there was histopathological evidence of thymocyte depletion 
in rabbits inoculated with RH/K34 (Fig. 1 A ). In contrast, 
rabbits  given the same or higher doses of R_H/K30 devel- 
oped low-grade leukemia; no thymic lesions were observed 
in these animals (Fig.  1 B) or in the rabbit inoculated with 
normal rabbit PBMC. Transmission electron microscopy of 
thymuses from RH/K34-inoculated rabbits,  but not RH/ 
K30-inoculated rabbits, revealed numerous apoptotic thymo- 
cytes characterized  by condensed cytoplasm containing in- 
tact organelles,  peripheral  chromatin condensation, and nu- 
dear segmentation (Fig. 1 C). In addition, DNA from depleted 
rabbit thymuses show an oligonudeosomal fragmentation pat- 
tern characteristic  of apoptosis (not shown). The effects of 
RH/K34 on rabbit thymus are similar to those documented 
for HIV-1 (16) and for chicken anemia virus (20) infections 
where thymus depletion results  from apoptosis. 
HTLV-1 Particles  from RH/K34  Trigger Death of Lympho- 
cytes In Vitro.  Virus was isolated from HTLV-1 cell lines, 
RH/K34 and RH/K30, and tested for its effects on lympho- 
cytes. Rabbit PBMC, exposed to purified cell-free RH/K34 
virus particles,  showed a rapid and marked decrease in cell 
viability. In contrast, viability of rabbit lymphocytes exposed 
to RH/K30 virus particles,  or to medium alone,  remained 
relatively  constant (Fig.  2 A). 
Like the thymuses of rabbits inoculated with RH/K34 cells, 
PBMC exposed to virus particles from RH/K34 showed mor- 
phological features  characteristic  of apoptosis.  In contrast, 
cells exposed to RH/K30 virus particles or cultured in medium 
alone retained a normal appearance (not shown). Further evi- 
dence for breakdown of cellular DNA into oligonucleosome- 
size fragments in cells exposed to RH/K34 virus (Fig. 2 B, 
lane 4),  but not RH/K30 virus or medium alone (lanes 2 
and 3), confirm that virus from RH/K34 triggers death by 
apoptosis  in target cells. 
Human PBMC were exposed  to RH/K34 or RH/K30 
virus particles to determine whether virus passaged in rabbit 
cells would affect human cells. As with the rabbit PBMC, 
virus particles  from RH/K34, but not RH/K30, induced 
rapid death of human PBMC in vitro (Fig.  2 C). 
To determine whether constant exposure to virus is required 
for the induction of apoptosis,  rabbit PBMC were exposed 
to several different concentrations of virus for I h and washed, 
and extracellular virus was digested by trypsin treatment (17). 
Virus antigen levels in lysates of cells initially exposed to 50 
#g/ml virus dropped to 40 pg of HTLV-1 p24 protein after 
this  treatment,  less than  10 -6  of the viral  antigen in the 
original input. Dose response data (unpublished results and 
Fig. 3) indicate that constant exposure to such low virus con- 
centrations cause neither stimulation, nor apoptosis of PBMC, 
within the time frame evaluated.  Viability of the HTLV-1- 
exposed and trypsin-treated cells indicated that 1-h exposure 
to RH/K34 virus did not induce cell death (Fig.  2 D)  in 
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the HTLV-l-derived  cell  lines, tLH/K34  and RH/K30. x  200. (A) Thymus 
from rabbit 4 d after  inoculation  (dai) with RH/K34. Numerous  apop- 
totic thymocytes  with dark condensed  nuclei  surrounded  by dear spaces 
resulted in cortical  thymus  depletion. (B) Thymus  from rabbit at 10 dai 
with RH/K30 showing  normal  thymic  architecture.  (C) Transmission  elec- 
tron microscopy  revealing  cytoplasmic  and chromatin  condensation  with 
nuclear  segmentation,  characteristic  of  apoptosis  in thymocyte  from  a rabbit 
examined  4 dai with RH/K34; for comparison  the cell  profile  at the lower 
right is unaffected, x4650. 
Figure  2.  In vitro effects of purified HTLV-1 from RH/K34 and 
KH/K30 on rabbit and human  PBMC. (A) Cell viability  monitored  on 
cultures of rabbit PBMC  incubated  in medium  alone  (open squares), in the 
presence of 50 #g/ml of  virus from  KH/K30 (closed  triangles) or KH/K34 
(open circles).  (B) DNA fragmentation  in rabbit PBMC  exposed  to RH/K34 
virus. DNA was extracted  from  PBMC  cultured  for 24 h in medium  alone 
(lane 2), or in the presence of virus isolated  from RH/K30 (lane 3) or 
RH/K34 (lane 4). Lane 1 shows  Gel Marker 50-1,000 bp standard  (Re- 
search Genetics,  Huntsville,  AL). (C) Cell  viability  measured  for human 
PBMC cultured as in (A). (D) Viability  of rabbit PBMC after  brief ex- 
posure to 50/~g/ml RH/K30 (closed triangles) or RH/K34 (open circles) 
virus or medium  (open squares). After 1 h exposure to virus or medium 
at 37~  cultures  were  treated  with trypsin,  washed, and incubated  at 37~ 
the same rapid time frame as when rabbit PBMC were con- 
stantly exposed (Fig. 2 A). At 4 d, cells pulsed with KH/K34 
virus particles  showed significantly decreased viability, com- 
pared to those similarly exposed  to  RH/K30 virus or to 
medium alone (Fig.  2 D). 
Consistent with previous reports that virus isolated from 
HTLV-l-infected T cells induced proliferation of human lym- 
phocytes (23) and thymocytes (24), RH/K30  virus stimulated 
thymidine incorporation by rabbit PBMC in a dose-dependent 
manner (Fig.  3).  In marked contrast,  KH/K34 virus  (in 
amounts >5/xg p24/ml) inhibited cell activation. Identical 
results were obtained with PBMC from an HTLV-l-infected 
rabbit (not shown). The effects of tLH/K34 and KH/K30 
virus on PBMC were also observed in the presence of exoge- 
nous rlL-2; KH/K34 virus particles  inhibited IL-2-driven 
proliferation, while RH/K30 virus acted synergistically to 
give greater levels of proliferation (Fig.  3).  Although IL-2 
was reported to inhibit spontaneous apoptosis  of T lympho- 
cytes from ATLL patients in culture (29), it did not prevent 
apoptosis  induced by RH/K34 virus in PBMC. 
Cell  Populations  Undergoing  RH/K34-mediated  Apoptosis. 
Cells targeted by R/-I/K34 virus particles were identified by 
flow cytometric analysis  of cell  populations  stained with 
ethidium bromide (EtBr) and mAbs to cell surface antigens 
CD4, CD8,  and Ig.  In agreement with reports that EtBr 
stains nucleic acids in cells undergoing apoptosis (15), fre- 
quencies of EtBr-positive cells corresponded to the frequency 
of nonviable cells, as determined by trypan blue exclusion. 
Analyses indicated that 40%  of cells exposed to RH/K34 
virus particles were EtBr positive, compared with 5% of cells 
exposed to KH/K30 virus particles or in medium alone (Fig. 
4). A relatively high percentage of apoptotic cells expressed 
CD4,  whereas most CD8 +  and Ig + cells  remained EtBr 
negative. Interpretations of these experiments must take into 
account the distribution of surface markers on rabbit lym- 
phocytes. About 10% of rabbit blood lymphocytes bear the 
CD8 marker, about 28% bear CD4,  and as many as 25% 
are TCK/3'~5 cells lacking CD4 and CD8 (27). Although it 
is not possible  to define  precise targets for the virus from 
these data, the population undergoing apoptosis contains more 
T  cells than B cells. 
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Figure  3.  Effects of  purified RH/K30  and  KH/K34 virus on 
[3H]thymidine incorporation  in cultured rabbit PBMC. Thymidine  up- 
take in presence of different  concentrations  of RH/K30 (shaded and striped 
Mrs) or RH/K34 (open and black Mrs). Cultures  designated  by shaded or 
solid black  bars contained  IL-2. Stimulation  indices  are calculated  by refer- 
ence to PBMC  maintained  in identical  cultures,  to which  no virus  was added. 
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Host Cell Factors Influence Virus-induced At, optosis.  The rele- 
vant differences between the HTLV-1 isolate from RH/K34 
that mediates apoptosis and the virus from RH/K30 that 
causes lymphoproliferation  are not known. Explanations based 
upon structural differences of the virus proteins are difficult 
to support, since the two viral genomes differ by only 0.2% 
and have identical envelope  sequences  (12). In addition, a 
CD4-, CD8 +, TCR/ot3  rabbit T cell line, RI-IT16,  which 
has  an  HTLV-1  provirus  sequence  identical  to  that  of 
RH/K34, did not cause leukemia in rabbits (12); nor did 
purified RHT-16  virus  induce lymphocyte apoptosis (not 
shown). 
Virus-associated  host  cell  proteins  may play  a  role  in 
virus-cell interactions. Recent reports indicate that cell sur- 
face proteins, including class I and II MHC molecules,  are 
incorporated into retrovirus membranes during the budding 
process (30). Allogeneic differences between MHC proteins 
on the virus membrane (from the host cell) and those on 
target cells are not likely to cause lymphoproliferative responses 
because PBMC preparations from different rabbits, as weU 
as from human subjects, all reacted in a similar fashion. Analysis 
of the cell lines showed that both RH/K34 and RH/K30 
are CD4-,  CD8-, TCR/y/~ T  cells, and both equally ex- 
press most markers tested, including TNF-oe, LFA3, IL-l-3, 
CD5, CD25, CD43, and CD44 (27 and unpublished data). 
However, one potentially significant difference is the expres- 
sion of the leukocyte common antigen CD45:RH/K34 ex- 
presses significantly higher levels of CD45 than RH/K30 (not 
shown). Since tyrosine phosphorylation has been associated 
with the cytopathic effects of HIV-1 (31), the expression  of 
this tyrosine phosphatase by RH/K34 may play a role in its 
pathogenesis. Similar to the present data, phosphatase activity 
associated with murine leukemia virus appears to correlate 
with its ability to cause leukemia in mice (32). However, other 
CD45 §  HTLV-l-infected cell  lines,  including  RHT-16, 
were not lethal in vivo and did not induce apoptosis in vitro. 
This result suggests that CD45 is necessary, but not suffident, 
for HTLV-1 apoptotic potential. 
To determine whether the RH/K34 virus produced by 
human, rather than rabbit, cells would induce apoptosis,  ir- 
radiated P,H/K34 and RH/K30 cells were used as a source 
for the infection of P,  PMI 8226, a human myeloma cell line. 
Two HTLV-1-infected cell lines RPMI K30 and RPMI K34, 
derived from the human line,  expressed  high levels of p24 
and produced mature HTLV-1 particles,  as assessed by elec- 
tron microscopic analysis (not shown). Rabbits inoculated 
with 3  x  10  s live RPMI K34, or RPMI K30 cells, showed 
no abnormality in temperature,  weight, or other clinical signs 
of disease. However, both rabbits produced anti-HTLV-1 an- 
tibodies from 2 wk after inoculation, and HTLV-1 sequences 
,  were detected in PBMC by PCR amplification beginning 8 
wk after inoculation (not shown). Furthermore, sucrose gra- 
dient-purified virus particles from RPMI K34 supernatants 
were unable to induce death of rabbit or human PBMC in 
vitro.  Therefore,  data from both  rabbit  and human cell- 
derived virus emphasize the importance of the infected cell 
phenotype, as opposed to primary virus structure, in the patho- 
genic potential of the HTLV-1. 
Human T Lymphocyte  Virus 1-induced Lymphocyte  Apoptosis 
Ethidium  Bromide (red) Fluorescence 
Figure 4.  Flow  cytometry  of rabbit PBMC exposed to virus from 
R.H/K34 or RH/K30. Rabbit PBMC were cultured at 37~  in medium 
alone or in presence of purified virus particles. Cells were reacted with 
mAb to rabbit CD4, CD8, or surface  Ig and with ethidium  bromide and 
analyzed  by flow  cytometry.  Cells  cultured  in medium  alone  at 4~  were 
used as negative control for EtBr staining. 
1578 Numerous reports show apoptosis as a routine consequence 
of virus-host interaction for certain viruses (16-21). By con- 
trast,  apoptosis is not commonly associated with exposure 
to HTLV-1. Induction of apoptosis in both human and rabbit 
lymphocytes is peculiar to the lethal leukemogenic cell line 
RH/K34 or its isolated virus. The relevance of these findings 
to the variable pathogenic effects of human HTLV-1 infec- 
tion is supported by early observations of thymus depletion 
in ATLL patients  (33). The present  data implicate  virus- 
mediated apoptosis as a mechanism for such depletion and 
allow an in vitro means to investigate pathogenic isolates of 
HTLV-1. 
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